Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Commercial Insight: HIV - The battle for market share is getting fiercer | Aug 2008 | £9,615 | 100% |
| HIV/AIDS Therapeutics Pipeline Assessment and Market Forecasts to 2017 |
Apr 2011 | £1,265 | 99% |
| HIV-AIDS – Pipeline Assessment and Market Forecasts to 2016 | Jun 2010 | £1,265 | 98% |
| HIV-Associated Lipodystrophy Therapeutics Pipeline Assessment and Market Forecasts to 2017 |
Jun 2011 | £1,265 | 98% |
| Antivirals Market to 2016 Antiretroviral Agents and Combination Therapies to be Major Drivers HIV and Hepatitis C Markets |
Jan 2011 | £2,215 | 98% |
| Global HIV Therapeutics Market Analysis | Dec 2011 | £760 | 95% |
| Specialty Pharmaceutical Industry 2011 Yearbook |
May 2011 | £2,215 | 91% |
| Infectious Immunology Reagents, Instruments and Test Kits Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 |
Mar 2011 | £2,215 | 85% |
| HIV/AIDS Testing | Oct 2010 | £2,845 | 84% |
| Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast 2011-2016 |
Jan 2012 | £630 | 83% |
| The Clinical Laboratory Services Market Growth Opportunities, Competitive Analysis and Competitor Profiles |
Feb 2010 | £2,215 | 81% |
| Point of Care Diagnostics Players, Products & Future Market Prospects |
Jan 2012 | £995 | 81% |
| Gilead Sciences PharmaVitae Profile |
Oct 2010 | £3,605 | 80% |
| South African Healthcare Market Analysis | Apr 2011 | £630 | 80% |
| Pharmaceutical Pricing Global perspectives |
Sep 2004 | £625 | 78% |
| The US Pharmaceutical Market 2009-2024 | Nov 2009 | £1,499 | 77% |
| The Global Market for Pain Management Drugs and Devices | Aug 2009 | £3,065 | 75% |
| Russian Pharma Sector Analysis | Aug 2008 | £350 | 75% |
| Comparative Analysis of Late Stage Pipeline Molecules in Major Indications Oncology Pipeline Leads with Most Promising Molecules in Late Stage Development |
Jul 2011 | £2,215 | 73% |
| Top Companies and Products in the RNA/DNA Therapy Products Market Forecasts: The Challenge Of Turning Technology Into Therapy |
Jul 2007 | £1,999 | 73% |
| Condoms | Aug 2010 | £2,845 | 73% |
| Emerging Market for Clinical Trials in Russia Curbs on New Drug Approval Timelines and Registration Fees Encourage the Emergence of a Major Global Player |
Jul 2011 | £2,215 | 72% |
| US Diagnostic Market Outlook to 2014 | Dec 2011 | £630 | 72% |
| Gene Therapy | Jan 2011 | £2,845 | 71% |
| Market Potential for Hospital Services, Pharmaceuticals and Medical Devices in US | Sep 2008 | £315 | 70% |
| Global In Vitro Diagnostic Market Analysis | Dec 2011 | £1,010 | 69% |
| The Outlook for Pharmaceuticals in North East Asia | Nov 2011 | £1,995 | 69% |
| Hepatitis C (HCV) Market Forecast & Drugs Pipeline Analysis to 2016 | Jan 2011 | £680 | 68% |
| Post Marketing Clinical Research Rems, The Latest Reformation Due to Post Marketing Surveillance to Enhance Patient Compliance |
Sep 2011 | £2,215 | 68% |
| Flow Cytometry: Products, Technologies and Global Markets | Jun 2011 | £3,065 | 68% |
